
Larotrectinib was the first drug to receive accelerated FDA approval for patients of all ages based on a common molecular marker, independent of tissue origin for targeted therapy.

Larotrectinib was the first drug to receive accelerated FDA approval for patients of all ages based on a common molecular marker, independent of tissue origin for targeted therapy.

Applying these findings in practice could improve clinicians’ ability to offer truly personalized cancer therapy by enabling consideration of toxicity along with other data predicting patients’ responses.

A product containing phosphoric acid as well as alcohol successfully neutralized all of the virus particles.

Fecal microbiota transplantation produces cure rates of 82%-88% in patients with recurrent clostridium difficile infections.

Selinexor demonstrated a 37% increase in probability that patients treated with the drug will be in remission at 12 months.

The use of a unique trimer to produce tier-2 neutralizing antibodies may help fight HIV.

Vazalore has been shown to cause fewer stomach-related adverse effects than traditional aspirin.

Pain from golfer's elbow may spread into the forearm and wrist.

Sutimlimab-jome is the only approved treatment for individuals with CAD and works by inhibiting the destruction of red blood cells.

The uncommon disease shares features of both lymphoma and myeloma.

The majority of study participants demonstrated improvement of infraorbital hollows through 1 year.

The agency has also approved the baclofen oral suspension for Azurity Pharmaceuticals to treat individuals with other spinal cord diseases or injuries.

Following the first 3 days after a COVID-19 diagnosis, the risk of stroke quickly decreased.

Data have shown that patients with treatment-resistant anxiety, depression, and post-traumatic stress disorder are among those who would benefit from an expanded treatment offering that would include psychedelic medicines.

Monoclonal antibodies are highly effective at treating the virus, but they have often gone to the healthiest patients, instead of those over aged 65 years.

PainBloc inhibits joint pain from arthritis at the source.

Culturally tailored patient navigation can improve underserved individuals’ health literacy, trust in the health care system, and use of cancer screening tools, study results show.

Ten quiz questions to assess your knowledge on common symptoms and treatments for psoriasis.

Growing pains may be linked to a lowered pain threshold or, in some cases, to psychological issues.

The results of a pilot program investigating the efficacy of remote patient monitoring for patients with cancer showed that it helped to keep high-risk individuals out of the hospital.

Communication, flexibility, and virtual solutions will remain key as the COVID-19 pandemic continues.

Effective specialty pharmacies learn to meet the changing needs of patients and stakeholders.

The industry has been ushered into a new age of medicine.

Trametinib emerged as a novel therapeutic approach for low-grade serous carcinoma due to a high prevalence of activating mutations in the mitogen-activated protein kinase signaling pathway.

Millions of people are still getting COVID-19, so the need for additional tools to fight the virus remains strong.

But 3 main challenges stand in the way of their adoption: patent litigation, patient and physician concerns, and rebates and reimbursements.

Investigators also found that intravenous immunoglobulins tend to be associated with increased frequency, though not significant, of serious adverse events.

The vaccine targets the outer surface protein A of Borrelia burgdorferi, which is the bacteria that cause Lyme disease.

Pfizer and BioNTech are seeking an Emergency Use Authorization for their COVID-19 vaccine to include children 6 months through 4 years of age.

Although the researchers were able to find an association between a heart attack and faster cognitive decline, the findings did not establish that a heart attack directly causes cognitive decline.